FundedIQ
Health Care

Biosency: Funding, Investors & Team (Sep 2026)

BIOSENCY is a medical device company focused on developing smart healthcare solutions. Our first product, a connected PPG sensor system using smart data is a monitoring and prevention solution dedicated to respiratory insufficiency. Our company is based in Rennes, France. We work closely with doctors and researchers to bring to the medical community the best possible tools to help patients.

www.biosency.com LinkedIn Rennes, France 11-50 employees
Health Care Medical Device B2B
Total raised
$7.5M
Rounds
1
Latest
Undisclosed round
Nov 2023

Biosency has raised $7.5M across 1 funding round on record, the most recent an undisclosed round of $7.5M announced in Nov 2023.

That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

Biosency Company Profile and Key Stats

Total funding raised
$7.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$7.5M in Nov 2023
Employees
11-50
reported band
Headquarters
Rennes, France

Latest funding round on record: Nov 2023.

Biosency Funding Rounds

Date
Round
Amount
Undisclosed round
$7.5M

Biosency Founders and Leadership Team

Name
Role
Contact
Marie Pirotais
CEO

No contact details are on record for this team yet.

Biosency Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
1,705
$6.7M

Biosency's latest round of $7.5M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Biosency in Health Care and Rennes

Companies Similar to Biosency

Beams is a producer of medical devices for cancerology based on the use of particles β.

Undisclosed round $1.7M

Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.…

Undisclosed round

CILcare specializes in providing drug solutions for hearing and ear disorders.

Undisclosed round

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials,…

Undisclosed round $58.1M

noa is a digital fitness and wellness company that offers premium, structured training programs for strength,…

Seed $5.8M

Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in…

Undisclosed round $24.7M

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the…

Seed $13.0M

Axomove is an e-wellbeing application that spends significant time in video actual activities.

Series A $4.7M

Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate…

Series A $20.0M

May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is…

Undisclosed round $11.6M

MedinCell is an injectable slow-release drug specialist company.

Undisclosed round $55.7M

Charles helps men regain control over their daily health concerns by starting with their personal health.

Undisclosed round $300k

Biosency Funding FAQs

What does Biosency do?

BIOSENCY is a medical device company focused on developing smart healthcare solutions. Our first product, a connected PPG sensor system using smart data is a monitoring and prevention solution dedicated to respiratory insufficiency. Our company is based in Rennes, France. We work closely with doctors and researchers to bring to the medical community the best possible tools to help patients.

How much funding has Biosency raised?

Biosency has raised $7.5M across 1 round on record. The most recent is an undisclosed round of $7.5M announced in Nov 2023.

When did Biosency last raise funding?

Biosency's most recent funding round on record is an undisclosed round of $7.5M, announced in Nov 2023.

Who is the CEO of Biosency?

Marie Pirotais is listed as CEO at Biosency.

Where is Biosency headquartered?

Biosency is based in Rennes, Bretagne, France.

How many employees does Biosency have?

Biosency is in the 11-50 employee band.

How does Biosency's funding compare to other Health Care startups?

Biosency's latest round of $7.5M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Biosency Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biosency is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.